Liver cancer is the fifth most common cancer and the second leading cause of malignant
death in Asia, and Asia reports 72.5% of the world's cases in 2020. As the most common …

Mucosal administration, and specifically nasal route, constitutes an alternative and
promising strategy for drug and vaccine delivery. Mucosal routes have several advantages …

The importance of vaccination has been proven particularly significant the last three years,
as it is revealed to be the most efficient weapon for the prevention of several infections …

“Functional cure” is being pursued as the ultimate endpoint of antiviral treatment in chronic
hepatitis B (CHB), which is characterized by loss of HBsAg whether or not anti-HBs …

Hepatitis B virus (HBV) immunization is safe and has been accepted worldwide as a routine
practice. The target of such vaccination is to induce the immune response in the host …

Chronic hepatitis B infection remains a serious global health threat, contributing to a large
number of deaths through liver cirrhosis and hepatocellular carcinoma. Current treatment …

The currently recommended treatment for chronic hepatitis B virus (HBV) infection achieves
only viral suppression whilst on therapy, but rarely hepatitis B surface antigen (HBsAg) loss …

The last few years have seen a resurgence of activity in the hepatitis B drug pipeline, with
many compounds in various stages of development. This review aims to provide a …

Hepatitis B virus (HBV) infection, although preventable by vaccination, remains a global
health problem and a major cause of chronic liver disease. Although current treatment …

Hepatitis B virus (HBV) is a major cause of chronic hepatitis, liver cirrhosis, and
hepatocellular carcinoma. Despite the advent of vaccines and potent antiviral agents able to …